Oxygen Concentrators Market Size & Growth Forecast 2026–2035, By Segments (Product, Technology, Application), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape

Market Size and Growth Outlook

Oxygen Concentrators Market size was estimated at USD 3.82 Billion in 2025 and is projected to grow at a 5.4% CAGR from 2026 to 2035, reaching USD 6.46 Billion by 2035. The industry revenue for 2026 is assessed at USD 4 billion.

• Base Year Value (2025): USD 3.82 Billion
• CAGR (2026-2035): 5.4%
• Forecast Year Value (2035): USD 6.46 Billion
• Historical Data Period: 2022-2025
• Largest Region: North America
• Forecast Period: 2026-2035

Oxygen Concentrators Market Intelligence Snapshot:

• Regional Market Dynamics:

  • North America accounted for 43.46% of the market in 2025, supported by established home healthcare systems, broad diagnosis of respiratory diseases, and efficient distribution across hospitals and homecare providers.
  • Asia Pacific is projected to grow at a 6.1% CAGR due to expanding healthcare infrastructure, rising access to respiratory care, and wider adoption of home-based oxygen therapy.

• Segment Momentum:

  • Fixed Oxygen Concentrators accounted for 56.81% of the market in 2025 due to strong demand for continuous, long-duration oxygen therapy in home settings where reliability and higher output are priorities.
  • Portable Oxygen Concentrators are growing rapidly as patients increasingly seek mobility, convenience, and greater independence while maintaining ongoing oxygen therapy during daily activities and travel.

• Market Expansion Drivers:

  • Rising prevalence of chronic respiratory diseases increasing long-term oxygen therapy demand.
  • Expanding home healthcare adoption driving portable oxygen concentrator deployment.
  • Improved reimbursement policies expanding patient access to oxygen therapy devices.

• Leading Market Participants:

  Key players in the oxygen concentrators market include Inogen, Inc. (United States), Koninklijke Philips N.V. (Netherlands), Niterra Co., Ltd. (Japan), Drive DeVilbiss Healthcare (United States), Teijin Limited (Japan), React Health Holdings, LLC (United States), GF Health Products, Inc. (United States), O2 Concepts, LLC (United States), GCE Group (Sweden), BPL Medical Technologies Private Limited (India).

Unlock Complete Insights

Global Market Forecast Snapshot:

• Market Outlook:

  • 2025 Market Size: USD 3.82 Billion
  • 2026 Market Size: USD 15.2 billion
  • Projected Market Size: USD 6.46 Billion by 2035
  • Growth Forecasts: 5.4% CAGR (2026-2035)

• Regional and Segment Outlook:

  • Leading Regional Market: North America
  • High-Growth Regional Hub: Asia Pacific
  • Core Revenue Segment: Fixed Oxygen Concentrators (Product) | Continuous Flow (Technology) | Home Care (Application)
  • Emerging Opportunity Segment: Portable Oxygen Concentrators (Product) | Pulse Flow (Technology) | Home Care (Application)

Market Growth Drivers and Industry Trends

Rising prevalence of chronic respiratory diseases increasing long-term oxygen therapy demand

As chronic respiratory conditions such as COPD, severe asthma, and other persistent pulmonary disorders become more common, a larger patient pool requires sustained oxygen support outside acute care settings, increasing demand for the oxygen concentrators market. Long-term oxygen therapy changes purchasing behavior toward dependable, easy-to-maintain devices that can operate continuously in homes, rehabilitation settings, and outpatient care pathways. This pattern strengthens market development by increasing replacement cycles, service requirements, and physician-directed prescriptions for concentrators as part of routine disease management rather than short-term intervention.

Expanding home healthcare adoption driving portable oxygen concentrator deployment

The shift of respiratory care from hospitals to the home is reshaping product demand in the oxygen concentrators market toward lighter, mobile systems that fit daily living and remote care models. Portable oxygen concentrators are being adopted because patients and caregivers increasingly prioritize mobility, lower dependence on facility-based care, and simpler long-duration therapy management at home. That practical shift influences market adoption by pushing manufacturers, distributors, and care providers to emphasize compact design, battery performance, and user-friendly operation, which in turn supports broader device penetration among ambulatory patients.

Improved reimbursement policies expanding patient access to oxygen therapy devices

When reimbursement frameworks cover a greater share of equipment costs, the oxygen concentrators market benefits from a direct reduction in out-of-pocket barriers that often delay device adoption. Coverage expansion affects market behavior through higher prescription fulfillment, wider eligibility among chronic care patients, and greater willingness among providers and suppliers to recommend concentrators as a viable long-term therapy option. This contributes to market size growth by converting medically identified need into actual device uptake, especially in patient segments where affordability has historically constrained treatment continuity.

Growth Driver Assessment Framework
Growth Driver	Impact On CAGR	Regulatory Influence	Geographic Relevance	Adoption Rate	Impact Timeline
Rising prevalence of chronic respiratory diseases increasing long-term oxygen therapy demand	2.10%	High	North America, Europe	High	Near Term
Expanding home healthcare adoption driving portable oxygen concentrator deployment	1.80%	Moderate	North America, Asia Pacific	High	Near Term
Improved reimbursement policies expanding patient access to oxygen therapy devices	1.60%	High	North America, Europe	High	Near Term

Regional Demand Dynamics

North America (Largest Region) vs Asia Pacific (Fastest-Growing Region)

North America accounted for a 43.46% share of the oxygen concentrators market in 2025, bolstered by established home healthcare delivery, broad awareness and diagnosis of chronic respiratory conditions, and purchasing patterns that favor clinically reliable oxygen therapy devices. The region’s leadership is strengthened by healthcare systems that can absorb higher use of long-term respiratory support, along with a mature distribution network spanning hospitals, specialty providers, and homecare channels. In practice, this enables faster patient placement, replacement demand for aging devices, and steady uptake of portable and stationary units across both institutional and residential settings.

Asia Pacific is projected to expand at a 6.1% CAGR over the forecast period, with growth in the oxygen concentrators market being fueled by rising access to respiratory care, expanding healthcare infrastructure, and wider adoption of home-based treatment across densely populated countries. Demand is accelerating as more patients enter the diagnosed care pathway and providers seek practical oxygen delivery options that can be deployed beyond acute care environments. The region’s momentum is also shaped by increasing availability through local distributors and healthcare facilities, which supports broader use in urban and developing care markets alike.

Regional Market Attractiveness & Strategic Fit Matrix
Parameter	North America	Asia Pacific	Europe	Latin America	MEA
Innovation Hub	Advanced	Developing	Advanced	Developing	Developing
Cost-Sensitive Region	Low	High	Medium	High	High
Regulatory Environment	Supportive	Neutral	Supportive	Restrictive	Restrictive
Demand Drivers	Strong	Strong	Moderate	Moderate	Moderate
Development Stage	Developed	Developing	Developed	Emerging	Emerging
Adoption Rate	High	Medium	Medium	Low	Low
New Entrants / Startups	Dense	Moderate	Moderate	Sparse	Sparse
Macro Indicators	Strong	Strong	Stable	Stable	Weak

Key Country Insights

United States

Home Respiratory Care

The U.S. maintains strong demand for oxygen concentrators supporting home-based respiratory therapy and long-term patient management. Healthcare providers across the U.S. increasingly favor portable and connected devices that improve patient mobility while enabling remote monitoring capabilities.

Japan

Aging Care Solutions

Japan is strengthening adoption of oxygen concentrators to support an expanding elderly population requiring chronic respiratory care. Healthcare providers in Japan increasingly prioritize compact, quiet, and dependable devices suited for long-term home treatment.

South Korea

Connected Respiratory Devices

South Korea is incorporating oxygen concentrators into digitally enabled healthcare services that support remote patient management. Medical providers in South Korea are adopting advanced portable systems designed to improve treatment continuity and patient convenience.

Germany

Clinical Equipment Modernization

Germany continues to invest in oxygen concentrators for hospitals, rehabilitation centers, and home healthcare settings. Demand in Germany reflects interest in reliable, energy-efficient systems that meet stringent medical device quality and performance expectations.

France

Home Healthcare Expansion

France continues to expand oxygen concentrator utilization within home healthcare programs for chronic respiratory conditions. Healthcare providers in France are emphasizing patient comfort, device reliability, and efficient service support to improve long-term treatment outcomes.

Italy

Community Care Support

Italy is increasing deployment of oxygen concentrators across community healthcare and home treatment settings. Demand in Italy is influenced by efforts to improve accessibility for respiratory care while encouraging dependable equipment with simplified maintenance requirements.

Segment Leadership and Growth Trends

  Product Segment Analysis: Fixed Oxygen Concentrators (Largest Segment) vs Portable Oxygen Concentrators (Fastest-Growing Segment)

Fixed Oxygen Concentrators held the leading position in the oxygen concentrators market in 2025, accounting for a 56.81% share. Their leadership is underpinned by steady demand from patients who require long-duration oxygen therapy in home-based settings where continuous access, higher output capability, and less dependence on mobility are central to treatment use. In the oxygen concentrators market, fixed systems remain widely adopted because they align well with routine respiratory care needs that prioritize dependable operation over portability.

Portable Oxygen Concentrators are emerging as the fastest-growing product segment in the oxygen concentrators market as patient preference shifts toward greater mobility and less restrictive oxygen therapy. Growth is being supported by practical use cases in which users want to maintain daily activity, travel more easily, and reduce the limitations associated with stationary equipment. Compared with fixed alternatives, portable units are seeing wider adoption because they better fit evolving care expectations centered on convenience and independence without moving away from oxygen support.

Technology Segment Analysis: Continuous Flow (Largest Segment) vs Pulse Flow (Fastest-Growing Segment)

Continuous Flow represented the largest technology segment in the oxygen concentrators market in 2025, with a 57.65% share. Its market leadership is tied to its suitability for patients who need uninterrupted oxygen delivery, particularly in cases where consistent therapeutic support is more important than conserving device output. Within the oxygen concentrators market, this technology continues to hold the largest share because it serves a broad base of respiratory care requirements across home treatment settings.

Pulse Flow is the fastest-growing technology segment in the oxygen concentrators market, encouraged by rising interest in more adaptive oxygen delivery approaches that better support mobility and everyday use. Its momentum comes from practical advantages in scenarios where patients do not require constant flow and instead benefit from oxygen delivery that responds to breathing patterns. Relative to continuous flow systems, pulse flow is gaining growth traction because it aligns more closely with the expanding use of lighter, more flexible oxygen therapy solutions.

Report Segmentation
Segment	Sub-Segment	Largest Segment	Fastest Growing Segment
Product	Portable Oxygen Concentrators, Fixed Oxygen Concentrators	Fixed Oxygen Concentrators	Portable Oxygen Concentrators
Technology	Continuous Flow, Pulse Flow	Continuous Flow	Pulse Flow
Application	Home Care, Non- Home Care	Home Care	Home Care

Competitive Landscape and Market Positioning

Top players in the oxygen concentrators market:

1. Inogen Inc. (United States)

2. Koninklijke Philips N.V. (Netherlands)

3. Niterra Co. Ltd. (Japan)

4. Drive DeVilbiss Healthcare (United States)

5. Teijin Limited (Japan)

6. React Health Holdings LLC (United States)

7. GF Health Products Inc. (United States)

8. O2 Concepts LLC (United States)

9. GCE Group (Sweden)

10. BPL Medical Technologies Private Limited (India)

Rising demand for home-based respiratory care is encouraging innovation across the oxygen concentrators market. Product development is focused on portable designs, smart monitoring capabilities, and energy-efficient systems that improve patient mobility, treatment convenience, and long-term oxygen therapy management.

Industry Development/News

Company Name	Date	Key Development
Unitaid	Mar-25	Unitaid expanded its regional oxygen production network into Tanzania via the East African Program on Oxygen Access. By coordinating investment with regional partners like TOL Gases Plc, the initiative targets a tripling of regional production capacity and a 25% price reduction, strengthening supply chain resilience and local medical oxygen self-sufficiency.
Oxymed	Apr-24	Oxymed launched the 5 LPM “Cure” oxygen concentrator in India, targeting the affordable home healthcare segment. The device features integrated purity monitoring and improved energy efficiency. By positioning the product at a competitive price point supported by a national service network, Oxymed aims to increase market penetration in the domestic home oxygen therapy space.
Inogen	Apr-24	Inogen introduced the Voxi 5 stationary oxygen concentrator, marking a strategic expansion of its portfolio beyond portable devices. This move allows the company to address the long-term care needs of residential and home-based patients, leveraging its existing distribution infrastructure to capture greater share in the stationary oxygen therapy market.
Inogen	Feb-24	Inogen launched the Rove 4 portable oxygen concentrator, featuring enhanced flow settings capable of delivering 840 ml/min. This product development reinforces the company’s focus on high-performance, mobility-oriented respiratory solutions, addressing the demand for continuous oxygen therapy among active patient populations.
Unitaid	Mar-24	Unitaid, in collaboration with MedAccess and Synergy Gases Ltd, launched a financing and manufacturing initiative to scale oxygen access across sub-Saharan Africa. The program focuses on establishing regional production networks and improving supply reliability in underserved healthcare systems, representing a major strategic investment in critical respiratory infrastructure.